These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 28583524

  • 21. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G, Boucher HW.
    Clin Infect Dis; 2008 Sep 01; 47(5):702-11. PubMed ID: 18652557
    [Abstract] [Full Text] [Related]

  • 22. Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
    Isada CM, Yen-Lieberman B, Lurain NS, Schilz R, Kohn D, Longworth DL, Taege AJ, Mossad SB, Maurer J, Flechner SM, Mawhorter SD, Braun W, Gordon SM, Schmitt SK, Goldman M, Long J, Haug M, Avery RK.
    Transpl Infect Dis; 2002 Dec 01; 4(4):189-94. PubMed ID: 12535261
    [Abstract] [Full Text] [Related]

  • 23. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.
    Fisher CE, Knudsen JL, Lease ED, Jerome KR, Rakita RM, Boeckh M, Limaye AP.
    Clin Infect Dis; 2017 Jul 01; 65(1):57-63. PubMed ID: 28369203
    [Abstract] [Full Text] [Related]

  • 24. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P, Schmiedeskamp M, Neeley H, Oberholzer J, Benedetti E, Kaplan B.
    Transpl Infect Dis; 2008 Apr 01; 10(2):129-32. PubMed ID: 17605740
    [Abstract] [Full Text] [Related]

  • 25. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D, Ogawa Y, Fujita H, Morita K, Sasaki H, Oishi Y, Higuchi H, Hatanaka K, Shinohara N.
    Nephrology (Carlton); 2016 Jul 01; 21 Suppl 1():63-6. PubMed ID: 26970406
    [Abstract] [Full Text] [Related]

  • 26. Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
    Jung JY, Nho D, Cho SY, Lee DG, Choi SM, Kim HJ, Kim M, Oh EJ.
    J Infect Chemother; 2022 Oct 01; 28(10):1415-1418. PubMed ID: 35810104
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
    Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC, Drew WL.
    J Infect Dis; 1997 Sep 01; 176(3):786-9. PubMed ID: 9291334
    [Abstract] [Full Text] [Related]

  • 29. New developments in the management of cytomegalovirus infection after solid organ transplantation.
    Eid AJ, Razonable RR.
    Drugs; 2010 May 28; 70(8):965-81. PubMed ID: 20481654
    [Abstract] [Full Text] [Related]

  • 30. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
    Nawashiro Y, Shiraki K, Yamamoto S, Takizawa K, Sasada Y, Suehiro M, Miura K, Hattori M, Daikoku T, Hisano M.
    Transplant Proc; 2018 Dec 28; 50(10):3932-3936. PubMed ID: 30577289
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
    Minces LR, Nguyen MH, Mitsani D, Shields RK, Kwak EJ, Silveira FP, Abdel-Massih R, Pilewski JM, Crespo MM, Bermudez C, Bhama JK, Toyoda Y, Clancy CJ.
    Antimicrob Agents Chemother; 2014 Dec 28; 58(1):128-35. PubMed ID: 24145525
    [Abstract] [Full Text] [Related]

  • 34. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.
    Boivin G, Goyette N, Gilbert C, Humar A, Covington E.
    Transpl Infect Dis; 2005 Dec 28; 7(3-4):166-70. PubMed ID: 16390409
    [Abstract] [Full Text] [Related]

  • 35. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
    Garrigue I, Moulinas R, Recordon-Pinson P, Delacour ML, Essig M, Kaminski H, Rerolle JP, Merville P, Fleury H, Alain S.
    J Clin Virol; 2016 Jul 28; 80():74-81. PubMed ID: 27214758
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of sequential cytomegalovirus isolates in a patient with lymphoma and failing antiviral therapy.
    Ducancelle A, Belloc S, Alain S, Scieux C, Malphettes M, Petit F, Brouet JC, Sanson Le Pors MJ, Mazeron MC.
    J Clin Virol; 2004 Apr 28; 29(4):241-7. PubMed ID: 15018851
    [Abstract] [Full Text] [Related]

  • 38. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF.
    Antiviral Res; 2016 Oct 28; 134():58-62. PubMed ID: 27582067
    [Abstract] [Full Text] [Related]

  • 39. Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy.
    Mendez JC, Sia IG, Tau KR, Espy MJ, Smith TF, Chou S, Paya CV.
    Transplantation; 1999 Mar 15; 67(5):755-7. PubMed ID: 10096535
    [Abstract] [Full Text] [Related]

  • 40. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
    Yang SL, Lin TW, Lin HC, Wang HY, Chang PY, Wang PN, Yang S, Lu JJ.
    J Microbiol Immunol Infect; 2021 Oct 15; 54(5):971-978. PubMed ID: 33632621
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.